Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    July 2017
  1. TRUONG M, Rais-Bahrami S, Nix JW, Messing EM, et al
    Perineural Invasion by Prostate Cancer on MR/US Fusion Targeted Biopsy is Associated with Extraprostatic Extension and Early Biochemical Recurrence after Radical Prostatectomy.
    Hum Pathol. 2017 Jul 10. pii: S0046-8177(17)30239.
    PubMed     Text format     Abstract available


    May 2017
  2. RONEN S, Abbott DW, Kravtsov O, Abdelkader A, et al
    PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
    Hum Pathol. 2017 May 10. pii: S0046-8177(17)30154.
    PubMed     Text format     Abstract available


    March 2017
  3. HAMMERICH KH, Frolov A, Li R, Ittmann M, et al
    Cellular Interactions of The Phosphorylated Form of AKT in Prostate Cancer.
    Hum Pathol. 2017 Mar 11. pii: S0046-8177(17)30065.
    PubMed     Text format     Abstract available


    December 2016
  4. BARAS AS, Nelson JB, Han M, Parwani AV, et al
    The Effect of Limited (Tertiary) Gleason Pattern 5 on the New Prostate Cancer Grade Groups.
    Hum Pathol. 2016 Dec 16. pii: S0046-8177(16)30346.
    PubMed     Text format     Abstract available


    November 2016
  5. FIGIEL S, Vasseur C, Bruyere F, Rozet F, et al
    Clinical significance of epithelial-mesenchymal transition (EMT) markers in prostate cancer.
    Hum Pathol. 2016 Nov 3. pii: S0046-8177(16)30284.
    PubMed     Text format     Abstract available


    June 2016
  6. VOLANTE M, Tota D, Giorcelli J, Bollito E, et al
    Androgen deprivation modulates gene expression profile along prostate cancer progression.
    Hum Pathol. 2016 Jun 21. pii: S0046-8177(16)30119.
    PubMed     Text format     Abstract available


    May 2016
  7. BAUMAN TM, Vezina CM, Ricke EA, Halberg RB, et al
    Expression and colocalization of beta-catenin and lymphoid enhancing factor-1 in prostate cancer progression.
    Hum Pathol. 2016;51:124-33.
    PubMed     Text format     Abstract available


  8. KOSAKA T, Mikami S, Yoshimine S, Miyazaki Y, et al
    The prognostic significance of OCT4 expression in patients with prostate cancer.
    Hum Pathol. 2016;51:1-8.
    PubMed     Text format     Abstract available


    March 2016
  9. PERROUIN VERBE MA, Bruyere F, Rozet F, Vandier C, et al
    Expression of store-operated channel components in prostate cancer: the prognostic paradox.
    Hum Pathol. 2016;49:77-82.
    PubMed     Text format     Abstract available


  10. SADIMIN ET, Ye H, Epstein JI
    Should the involvement of skeletal muscle by prostatic adenocarcinoma be reported on biopsies?
    Hum Pathol. 2016;49:10-4.
    PubMed     Text format     Abstract available


    February 2016
  11. GOLDSTEIN J, Borowsky AD, Goyal R, Roland JT, et al
    Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (MAGI-2) in prostate cancer: an immunohistochemical study.
    Hum Pathol. 2016 Feb 4. pii: S0046-8177(16)00035.
    PubMed     Text format     Abstract available


    January 2016
  12. BINGHAM V, Ong CW, James J, Maxwell P, et al
    PTEN mRNA detection by chromogenic, RNA in situ technologies: a reliable alternative to PTEN immunohistochemistry.
    Hum Pathol. 2016;47:95-103.
    PubMed     Text format     Abstract available


    November 2015
  13. BAUMAN TM, Becka AJ, Sehgal PD, Huang W, et al
    SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-kappaB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
    Hum Pathol. 2015;46:1744-51.
    PubMed     Text format     Abstract available


    October 2015
  14. PUST A, Kylies D, Hube-Magg C, Kluth M, et al
    Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence.
    Hum Pathol. 2015 Oct 22. pii: S0046-8177(15)00388.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: